Skip to content
Bomb Report – Lifestyle
Author:
Zealand Pharma
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
March 7, 2026
←
Previous Page
1
2
3
4